
NeoMab™: A Novel Platform for Fully Human Therapeutic Antibody Development
GemPharmatech has developed a novel mouse model that produces fully human antibodies known as the NeoMab™. NeoMab™, developed on the widely utilized BALB/c genetic background, maintains a robust immune system and MHC molecules for improved antigen presentation, exhibiting strong humoral immune responses and confirmed production of high-affinity antibodies against various antigens.
Download